Novel prophylactic anticoagulation scoring tool helps stratify patients following lower limb trauma
1. The 3-month symptomatic venous thromboembolism rate was 0.7% in patients with TRiP(cast) score...
Read MoreApr 12, 2024
1. The 3-month symptomatic venous thromboembolism rate was 0.7% in patients with TRiP(cast) score...
Read MoreApr 11, 2024
1. Overall vaccine efficacy ranged from 83.1% to 86.6% during the 10-year period. 2. Detectable...
Read MoreApr 10, 2024
1. Intravascular imaging-guided PCI significantly reduces target lesion failure compared to...
Read MoreApr 9, 2024
1. Roughly 65% of the cancer medication budget is allocated to treatments that provide improvement...
Read MoreApr 9, 2024
1. The pathological response rate had an OR of 3.16 when comparing neoadjuvant dual vs single...
Read MoreApr 8, 2024
1. Patients randomized to receive the paravertebral block (PVB) and erector spinae plane block...
Read MoreApr 6, 2024
1. In this randomized controlled trial, omalizumab was superior to placebo in increasing the...
Read MoreApr 6, 2024
1. This retrospective study found that the use of medications for alcohol use disorder (MAUD)...
Read MoreApr 4, 2024
1. In this cohort study, neutralizing autoantibodies against interleukin-23 (anti-IL-23) were...
Read MoreApr 3, 2024
1. In this prospective study, patients with carotid artery stenosis with microplastics and...
Read MoreApr 3, 2024
1. 18-month recurrence-free survival was significantly greater in the combination therapy group...
Read MoreApr 2, 2024
1. Pazopanib did not improve disease-free survival in post-metastasectomy renal cell carcinoma...
Read MoreApr 2, 2024
1. The overall survival had a significant hazard ratio (0.65) when comparing neoadjuvant...
Read MoreMar 29, 2024
Click here to read this study in JAMA Network Open. ©2024 2 Minute Medicine, Inc. All rights...
Read MoreMar 28, 2024
1. Post-ERCP pancreatitis was more common in the indomethacin alone group compared to indomethacin...
Read MoreMar 26, 2024
1. Invasive disease-free survival was significantly higher in patients receiving adjuvant...
Read MoreMar 26, 2024
1. VENICE-1 observed high response rates (complete or partial remission) in both BCRi-naïve and...
Read MoreMar 26, 2024
1. 83.1% of patients with confirmed colorectal cancer had a positive cfDNA test meeting the...
Read MoreMar 26, 2024
1. Adding chemotherapy to immunotherapy did not prolong OS or PFS, with non-significant...
Read MoreMar 25, 2024
1. For women with cervical intraepithelial neoplasia grade 2 (CIN2), the risk of preterm birth was...
Read More